Monthly Archives: May 2011

Biosimilars Spend to Reach $2.5 Bln by 2015: IMS

Global spending on biosimilars is expected to reach between $2 and $2.5 billion by 2015, up from $311 million in 2010, according to an IMS forecast. Total spend on biologics is expected to climb as high as $200 billion. On a call with reporters yesterday, Murray Aitken, executive director of the IMS Institute for Healthcare Informatics, [...]
Posted in Agency Insight, Biotech, Emerging Markets, Europe, Strategy | Tagged , , | 2 Comments

Shrinks Like Latuda Over the Competition, Survey Finds

Psychiatrists are more likely to recommend Sunovion Pharmaceuticals’ Latuda to colleagues than Merck’s Saphris or Novartis’ Fenapt, according to a DTW Marketing Research survey. All three drugs are atypical antipsychotics indicated for schizophrenia, and had US launches in late 2009 (Saphris), early 2010 (Fenapt) and February of this year (Latuda). Latuda, however, appears to be gaining [...]
Posted in Advertising, Marketing, Sales, Strategy, patient compliance | Tagged , | 3 Comments

Will the iPad Replace the Rep?

By Beth Kennedy. With Big Pharma sales teams awash with iPads and 72% of US doctors now armed with smartphones for professional use, are we finally approaching the day when the rep is replaced by digital technology?  And if so, is it a good idea? The number of pharma sales reps industry has fallen by more than [...]
Posted in Guest Blog, Marketing, Sales, Strategy, social media | Tagged , , , , , | 2 Comments

Allergan Offers to Pay Journos to Discuss Botox

Physicians aren’t the only ones getting paid to attend industry-sponsored events heavy on product discussions. For $250, “select” journalists can discuss facial aesthetics at an event sponsored by Botox-maker Allergan, on June 9 in New York City. Journalistic ethics can be checked at the door. The emailed invitation to attend Allergan’s Facial Aesthetics Advisory Panel, which [...]
Posted in Events, Strategy, Uncategorized | Tagged , , , | 1 Comment

Gift Giving Must Stop Says ProPublica

According to ProPublica—though transparency has seemingly increased between pharma and physicians since the Christmastime release of its Dollars for Docs report—medical societies and organizations are still having a holiday with industry money. Three days before Christmas last year, independent news organization ProPublica released its own “naughty and nice” list in the form of its Dollars for [...]
Posted in Meetings, Regulatory | Tagged , , , | 1 Comment